PD-1 checkpoint inhibitor (Waterstone Pharmaceuticals)

N/A

Report date: 2025/03/20 15:32:20

Base Information

Drug NamePD-1 checkpoint inhibitor (Waterstone Pharmaceuticals)
Drug Alias Nameanti-human PD-1 mAb (Waterstone Pharmaceuticals)anti-human programmed cell death protein-1 mAb (Waterstone Pharmaceuticals)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWaterstone Pharmaceuticals (Wuhan) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWaterstone Pharmaceuticals (Wuhan) Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A